• Western blot analysis of various lysates, using ESRRB antibody (STJ115912) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) (STJS000856) at 1:10000 dilution. Lysates/proteins: 25 Mu g per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 1s.

Anti-ESRRB antibody (300-400) (STJ115912)

SKU:
STJ115912

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-ESRRB (300-400) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3.
Purification: Affinity purification
Dilution Range: WB 1:500-1:1000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: ESRRB
Gene ID: 2103
Uniprot ID: ERR2_HUMAN
Immunogen Region: 300-400
Immunogen: A synthetic peptide corresponding to a sequence within amino acids 300-400 of human ESRRB (NP_004443.3).
Immunogen Sequence: VYAEDYIMDEEHSRLAGLLE LYRAILQLVRRYKKLKVEKE EFVTLKALALANSDSMYIED LEAVQKLQDLLHEALQDYEL SQRHEEPWRTGKLLLTLPLL R
Post Translational Modifications Acetylated by PCAF/KAT2 (in vitro).
Function Isoform 3: Transcription factor that binds a canonical ESRRB recognition (ERRE) sequence 5'TCAAGGTCA-3' localized on promoter and enhancer of targets genes regulating their expression or their transcription activity. Plays a role, in a LIF-independent manner, in maintainance of self-renewal and pluripotency of embryonic and trophoblast stem cells through different signaling pathways including FGF signaling pathway and Wnt signaling pathways. Upon FGF signaling pathway activation, interacts with KDM1A by directly binding to enhancer site of ELF5 and EOMES and activating their transcription leading to self-renewal of trophoblast stem cells. Also regulates expression of multiple rod-specific genes and is required for survival of this cell type. Plays a role as transcription factor activator of GATA6, NR0B1, POU5F1 and PERM1. Plays a role as transcription factor repressor of NFE2L2 transcriptional activity and ESR1 transcriptional activity. During mitosis remains bound to a subset of interphase target genes, including pluripotency regulators, through the canonical ESRRB recognition (ERRE) sequence, leading to their transcriptional activation in early G1 phase. Can coassemble on structured DNA elements with other transcription factors like SOX2, POU5F1, KDM1A and NCOA3 to trigger ESRRB-dependent gene activation. This mechanism, in the case of SOX2 corecruitment prevents the embryonic stem cells (ESCs) to epiblast stem cells (EpiSC) transition through positive regulation of NR0B1 that inhibits the EpiSC transcriptional program. Also plays a role inner ear development by controlling expression of ion channels and transporters and in early placentation. Isoform 1: Transcription factor that binds a canonical ESRRB recognition (ERRE) sequence 5'TCAAGGTCA-3' localized on promoter and enhancer of targets genes regulating their expression or their transcription activity. Positively regulates ESR1 transcriptional activity upon E2 stimulation.
Protein Name Steroid Hormone Receptor Err2
Err Beta-2
Estrogen Receptor-Like 2
Estrogen-Related Receptor Beta
Err-Beta
Nuclear Receptor Subfamily 3 Group B Member 2
Database Links Reactome: R-HSA-383280
Cellular Localisation Nucleus
Cytoplasm
Chromosome
Alternative Antibody Names Anti-Steroid Hormone Receptor Err2 antibody
Anti-Err Beta-2 antibody
Anti-Estrogen Receptor-Like 2 antibody
Anti-Estrogen-Related Receptor Beta antibody
Anti-Err-Beta antibody
Anti-Nuclear Receptor Subfamily 3 Group B Member 2 antibody
Anti-ESRRB antibody
Anti-ERRB2 antibody
Anti-ESRL2 antibody
Anti-NR3B2 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance